Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00233714
Recruitment Status : Completed
First Posted : October 6, 2005
Last Update Posted : November 19, 2009
Information provided by:
Cordis Corporation